This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
autonomous-vehicles: Archive
Tesla's Robotaxi Plans for 2026: Is Musk's Timeline Finally Realistic?
by Rimmi Singhi
TSLA's robotaxi rollout is accelerating in Austin and beyond, but after past delays, can Musk's 2026 autonomy timeline finally hold up?
AMZNPositive Net Change TSLAPositive Net Change GOOGLPositive Net Change
autonomous-vehicles electric-vehicles self-driving-cars tech-stocks
Autoliv Q4 Earnings Surpass Expectations, Revenues Increase Y/Y
by Zacks Equity Research
ALV tops Q4 earnings and sales estimates as revenues rise 7.7% Y/Y, aided by new product launches.
FPositive Net Change ALVNegative Net Change PHINNegative Net Change
auto-tires-trucks autonomous-vehicles earnings
Gentex Q4 Earnings Match Estimates, Revenues Increase Y/Y
by Zacks Equity Research
GNTX Q4 EPS match estimates as revenues rise 19% Y/Y, margins expand and 2026 sales outlook edge higher.
FPositive Net Change GNTXNegative Net Change PHINNegative Net Change
auto-tires-trucks autonomous-vehicles earnings
Inside Tesla's $20B Capex Plan: How TSLA Is Shaping Its Future
by Rimmi Singhi
TSLA plans capex above $20B in 2026, ramping factories, AI compute, robotaxis and Optimus as it pushes beyond autos into AI and autonomy.
TSLAPositive Net Change METAPositive Net Change NBISPositive Net Change
artificial-intelligence auto-tires-trucks autonomous-vehicles electric-vehicles tech-stocks
Why Musk's Decision to End Model S/X Production Makes Sense for Tesla
by Rimmi Singhi
TSLA will end Model S and X to free factory space, cut low-return models, and accelerate its push into robots, autonomy, and AI-driven growth.
FPositive Net Change GMNegative Net Change TSLAPositive Net Change
artificial-intelligence auto-tires-trucks autonomous-vehicles electric-vehicles
Oshkosh Q4 Earnings Miss Estimates, Revenues Increase Y/Y
by Zacks Equity Research
Oshkosh reports a Q4 earnings miss but beats on revenues as higher sales across key segments drive a 3.5% Y/Y increase.
FPositive Net Change OSKNegative Net Change PHINNegative Net Change
auto-tires-trucks autonomous-vehicles earnings
Group 1 Q4 Earnings Miss Estimates, Revenues Increase Y/Y
by Zacks Equity Research
Group 1 Automotive posts Q4 EPS miss as profits fall, but revenues edge higher year over year on gains in used vehicles and parts and service.
FPositive Net Change GPINegative Net Change PHINNegative Net Change
auto-tires-trucks autonomous-vehicles earnings
Mercedes, NVIDIA and Uber Team Up to Build S-Class Robotaxis
by Zacks Equity Research
MBGYY is teaming up with NVIDIA and Uber to develop S-Class robotaxis, pairing MB.OS with DRIVE AV Level 4 for a premium autonomous ride.
NVDAPositive Net Change UBERNegative Net Change MBGYYPositive Net Change
auto-tires-trucks autonomous-vehicles electric-vehicles
Simmons First National (SFNC) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
SFNCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy First Bancorp (FBP) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
FBPNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines